There is a knitted elastic band, sold near the seasickness pills, with a plastic stud sewn inside it. You slide it up your wrist until the stud sits about three finger-widths below the crease of your palm, between the two tendons. That spot has a name in Chinese medicine, Neiguan, and a code in the research literature, PC6. Pressing on it is supposed to settle a queasy stomach.
In January 2004 the US Food and Drug Administration cleared a band of exactly that description for marketing, with an indication that reads, in the agency’s own file, as relief of nausea. In June 2013 the United Kingdom’s advertising regulator examined the same manufacturer’s claims about the same product and upheld complaints against every one of them.
Neither body was lying. They were answering different questions, and the gap between those questions is the most useful thing a reader can learn from this subject. So is a second gap, which sits inside the research itself.
Acupressure is the practice of applying sustained manual pressure to classical acupuncture points without breaking the skin. Its evidence base looks larger than it is, for a reason that is specific, demonstrable, and visible in the title of the most-cited review in the field.
A review of a point, not a technique
The flagship piece of evidence here is a Cochrane review by Anna Lee, Simon Chan and Lawrence Fan, updated in 2015, covering 59 trials and 7,667 participants. Its subject is the prevention of nausea and vomiting after surgery, and its title names PC6.
That wording is doing real work. The review is about stimulating a location, by any means. The interventions it pooled are listed in its own methods: acupuncture, electro-acupuncture, transcutaneous electrical acupoint stimulation, transcutaneous nerve stimulation, laser stimulation, capsicum plaster, an acu-stimulation device, and acupressure. A chili-pepper patch and a laser beam and a thumb are all in the same analysis.
The findings are genuinely favorable. Against a sham, stimulating PC6 cut the incidence of nausea by about a third, with a risk ratio of 0.68 across 40 trials and 4,742 participants, cut vomiting by about 40 percent, and cut the need for rescue anti-sickness drugs. Cochrane rated that evidence low quality, because the trials varied a great deal and many had design limitations, with 25 of the 59 at high risk of bias in at least one domain.
Against actual antiemetic drugs, including ondansetron, droperidol, metoclopramide and dexamethasone, the review found no difference in nausea, vomiting or rescue medication. It rated that comparison moderate quality, which is better than the sham comparison, and it went a step further. Using a statistical technique that estimates when a question has been answered, the reviewers concluded that further head-to-head trials against antiemetic drugs would be pointless.
That is a strong result and it should be reported plainly. It is also not a result about acupressure. It is a result about a point, with most of the statistical weight carried by needles and electrodes. Any article that renders it as proof that acupressure works for nausea has misread what was being counted.
The same point, three different answers
Because the evidence is organized by point rather than by technique, the honest way to grade it is one condition at a time. Do that and the picture stops being contradictory.
For nausea after surgery, the record above is the strongest acupressure has anywhere, with the borrowing caveat attached.
For nausea in early pregnancy, Cochrane reaches a different place. A review by Anne Matthews and colleagues, updated in 2015, covered 41 trials and 5,449 women up to 20 weeks of pregnancy. It found the evidence on PC6 acupressure, ear acupressure and electrical stimulation of PC6 to be limited, and found that acupuncture at PC6 or at traditional points showed no significant benefit. Its overall conclusion was blunt. Nobody has produced high-quality evidence for any single intervention, a statement the authors were careful to separate from the claim that the interventions fail.
For motion sickness, the National Center for Complementary and Integrative Health states, in a clinical digest dated June 2024, that the research does not back either acupressure or magnets as a remedy. That is the most direct negative statement from a federal health agency available on this topic, and it is current.
One practice, one point, three conditions, three verdicts. A claim that acupressure helps nausea without saying which nausea is not a summary. It is a category error.
Worth noting alongside that: the same federal center has no standalone page on acupressure at all. The practice appears only inside condition-specific digests on cancer symptoms, chronic pain and travel ailments. For an agency that maintains dedicated pages on acupuncture, massage, spinal manipulation and reflexology, that absence tells you how the field is organized. Acupressure is treated as a delivery method for something else, not as a subject.
The map the practice is built on, and who does the pressing
In the classical framework, points like Neiguan sit along meridians, which the tradition describes as channels carrying vital energy through the body. Pressure at a point is held to influence what happens along its channel, which is why a spot on the forearm is used for the stomach. That is the tradition’s own account, stated in its own vocabulary, and it is the reason PC6 rather than some other patch of skin became the one everybody tests. The wider system those channels belong to is taken up elsewhere in this library.
The measured effects described above do not confirm that account, and they do not refute it. Those are two separate questions and the research has only addressed one. A point can produce a result in a trial for reasons that have nothing to do with why it was selected, which is precisely what the sham-control literature on needling has spent twenty years failing to resolve.
One practical feature of acupressure follows from the mechanism and gets lost in the pooled analyses. Because nothing penetrates the skin, patients can apply it themselves, and in several trials that is exactly what happened. The 2006 chemotherapy review noted that pressure a patient applies to their own wrist seemed to offer some protection against acute nausea and “can readily be taught to patients,” while recording that the studies behind that finding had no placebo arm. Self-applied pressure sidesteps the cost, scheduling and access problems that limit needle-based care. It also means the person delivering the treatment is untrained, unblinded and highly motivated, which is a difficult combination to study.
So there are really two things sold under one word. One is a practitioner-delivered session, typically 30 to 60 minutes, often with the patient clothed, sometimes marketed under a named style. The other is a technique, a band or a printed diagram handed to a patient to use at home. The trial literature is mostly about the second, the commercial market is mostly about the first, and the evidence does not move between them automatically.
One product, two regulators, two verdicts
Here is what each of those 2004 and 2013 decisions certified.
A 510(k) clearance is not a finding that a device works. It is a finding that a device is substantially equivalent to a product already legally on the market, called a predicate. The wristband’s clearance letter lists predicates reaching back to a 1990 submission and a string of electrical stimulation devices from the late 1990s. The product code is MVV and the regulation is written for acupressure devices. Nothing in that file is a clinical efficacy review, and the file itself is internally inconsistent about the basics: the agency’s letter records the device as unclassified while the accompanying summary records it as Class II. Both statements sit in the same federal record.
The United Kingdom’s Advertising Standards Authority, ruling on 5 June 2013, did examine the efficacy evidence. The manufacturer submitted more than 40 studies and argued that compliance with European medical device rules settled the matter. The regulator said device regulation does not substitute for its own assessment of a marketing claim, and then went through the claims one by one.
On motion sickness, the most relevant adequately controlled study had tested manual pressure rather than the band and had found no significant difference from placebo. On morning sickness, the main randomized study of 97 women did not produce statistically significant results for the claims made. On cancer-related nausea, the studies addressed nausea caused by cancer treatment rather than by cancer, and had control weaknesses. On general nausea, all six supporting studies concerned postoperative patients and all six found no significant difference from placebo.
The ruling was upheld on four counts of the UK advertising code: misleading advertising, substantiation, exaggeration, and the rules governing medical claims. The company was told not to repeat the claims without clinical evidence capable of supporting them.
Put the two documents side by side and a reader learns something that transfers to every cleared device on a pharmacy shelf. A clearance says a product is enough like something already sold. An advertising ruling says whether the marketing can be backed up. They are not the same test, and only one of them looked at whether the thing works.
One further distinction gets collapsed constantly. The elastic band applies mechanical pressure. Other wrist devices sold for nausea deliver electrical stimulation at the same point, which is a different intervention. In Cochrane’s review of acupuncture-point stimulation for chemotherapy-related nausea, led by Jeanette Ezzo and published in 2006, those two came out differently in the same analysis. Acupressure reduced the severity of acute nausea, with a standardized mean difference of 0.19, and did nothing for vomiting or for delayed symptoms. Noninvasive electrical stimulation showed no benefit for any outcome measured.
That review carries a caveat that changes how its results read. Every trial in it gave patients anti-sickness drugs as well, and every trial except the electroacupuncture ones used the best drugs available at the time. Electroacupuncture is the one modality in that review with a clear benefit on vomiting, cutting the proportion of patients with acute vomiting at a risk ratio of 0.76, interval 0.60 to 0.97. It was also the only one tested against a weaker drug background, and the modalities tested against strong background treatment had less room to show anything. When a review compares add-on therapies, what the comparison group already received determines how much is left to measure.
Where acupressure stands in its own right
Strip out the pooled analyses and acupressure does have one mainstream guideline placement of its own, and it is not about nausea.
In 2022 the Society for Integrative Oncology issued a guideline on pain in cancer care jointly with the American Society of Clinical Oncology, built on 227 studies published between 1990 and 2021. Three practices are named together in one clause for general cancer pain and musculoskeletal pain: acupuncture, reflexology and acupressure. The panel judged benefit to outweigh risk, rated the evidence intermediate, and set the strength of its recommendation at moderate. It recorded that the evidence was insufficient to recommend anything for children.
That is the best standing acupressure holds in any mainstream guideline, and it concerns pain rather than sickness. It is also still a pooled recommendation.
The federal complementary health center’s own chronic pain digest, dated September 2022, carries the underlying research in the same shape. It reports a 2020 systematic review of 31 randomized trials and 2,031 patients in which acupuncture and acupressure, taken together, were associated with reduced cancer pain and reduced use of painkillers, at a moderate evidence level. Acupuncture and acupressure, taken together. The pairing is not sloppy writing. It is how the trials were designed and how the reviews were built, which is why separating the two is harder than it looks and why so few people try.
There is one more finding, and it is the easiest in this literature to over-read. A 2020 Cochrane review by Caroline Smith and colleagues examined acupuncture and acupressure separately for labor pain, across 28 trials and 3,960 women. Against a sham, acupressure was associated with a lower caesarean section rate, with a risk ratio of 0.44, and Cochrane rated that moderate certainty and wrote that acupressure probably reduces the caesarean rate.
Three things travel with that sentence and must. It rests on four trials and 313 women. Nobody has proposed a mechanism by which finger pressure would alter a surgical decision. And in the very same comparison, the pain intensity estimate was rated very low certainty, which means the review is more confident about the operating theatre than about the pain. Against a combined control, acupressure probably slightly reduced pain intensity, on moderate certainty, across two trials and 322 women. Most of the review’s other comparisons landed in low or very low certainty.
Safety, and the cautions nobody has published
The clearest thing that can be said about acupressure’s safety is structural rather than statistical. The skin is not broken, so the specific harms documented for needling do not transfer. There is no route for a collapsed lung, no retained needle, no bloodborne infection, no puncture of an organ. That is a logical consequence of the mechanism, not a finding from a safety study, and it should be read as such.
What the trials recorded is mild. Across 14 trials the PC6 review found that side effects were mild, short-lived and settled on their own, among them pain, redness, blistering and skin irritation. Blistering is worth a second look, because it almost certainly reflects the chili plasters and the electrical devices in that pooled set rather than a thumb.
Two honest limits belong here. First, a 2025 systematic review of serious adverse events after physical procedures aimed at the neck, led by Bryden Leung at the University of Queensland, catalogued 334 cases and noted that while most followed manipulation, some followed gentler things, naming vestibular testing, gentle mobilization, exercises, acupuncture and even massage. Non-forceful manual contact at the neck is not a documented zero.
Second, the contraindications you will see repeated everywhere, chiefly the warnings against pressing certain points during pregnancy, could not be traced to a regulator, a federal health agency or a peer-reviewed safety review for this article. They are standard practitioner teaching, taught consistently and in good faith, and they may well be sensible. They are not published guidance from any body this library cites, and they should not be presented as if they were.
The circumstances that call for professional care are specific. Vomiting that prevents you from keeping fluids down, nausea with severe abdominal pain, fever, a headache unlike your usual ones, or nausea with chest discomfort are reasons to be assessed rather than managed at the wrist. In pregnancy, nausea severe enough to cause weight loss or dehydration has a diagnosis and a treatment pathway, and the June 2024 federal digest notes that obstetric guidance recommends vitamin B6, alone or with doxylamine, for nausea and vomiting of pregnancy. During chemotherapy, nausea is managed by a protocol that the oncology team adjusts, and the Cochrane evidence above sits alongside that protocol rather than in place of it. No decision to start, stop, add or delay any of it belongs anywhere but with the clinician managing the case.
How to read the next claim you see
The blinding problem that haunts all of this, meaning the difficulty of designing a fake version of a hands-on treatment that patients cannot detect, has an article of its own here, on acupuncture, where the three-armed trial evidence lives.
What travels from here is a reading habit. Four questions will sort almost any claim you meet about a pressure point:
- What was the unit of analysis? A review of a point is not a review of a technique. Check whether needles, lasers or electrodes are inside the pooled estimate.
- Which condition? Postoperative nausea, pregnancy nausea, chemotherapy nausea and motion sickness have four different evidence records. A claim without a condition is not checkable.
- What was the comparator? Beating a sham and matching a drug are different achievements, and in this literature the second is the better-evidenced of the two.
- What did the reviewers rate the evidence? Cochrane prints its own certainty grade next to every estimate. Low and very low are not insults, but they are warnings, and they are on the record for most of the acupressure numbers in circulation.
The single most useful takeaway is the one the two regulators handed over for free. A product can be legally marketed with a nausea indication and still have no evidence that it relieves nausea, because the thing that let it onto the market was never a test of whether it works.
Keep exploring: acupuncture evidence and cupping therapy.
Sources
- Cochrane Database of Systematic Reviews. “Lee A, Chan SKC, Fan LTY. "Stimulation of the wrist acupuncture point PC6 for preventing postoperative nausea and vomiting." Cochrane Database Syst Rev, 2015 (59 trials, 7,667 participants). PubMed. DOI: 10.1002/14651858.CD003281.pub4.” pubmed.ncbi.nlm.nih.gov
- Cochrane Database of Systematic Reviews. “Matthews A, Haas DM, O'Mathuna DP, Dowswell T. "Interventions for nausea and vomiting in early pregnancy." Cochrane Database Syst Rev, 2015 (41 trials, 5,449 women). PubMed. DOI: 10.1002/14651858.CD007575.pub4.” pubmed.ncbi.nlm.nih.gov
- Cochrane Database of Systematic Reviews. “Smith CA, Collins CT, Levett KM, Armour M, Dahlen HG, Tan AL, Mesgarpour B. "Acupuncture or acupressure for pain management during labour." Cochrane Database Syst Rev, 2020 (28 trials, 3,960 women). PubMed. DOI: 10.1002/14651858.CD009232.pub2.” pubmed.ncbi.nlm.nih.gov
- Cochrane Database of Systematic Reviews. “Ezzo JM, Richardson MA, Vickers A, et al. "Acupuncture-point stimulation for chemotherapy-induced nausea or vomiting." Cochrane Database Syst Rev, 2006 (11 trials, 1,247 participants). PubMed. DOI: 10.1002/14651858.CD002285.pub2.” pubmed.ncbi.nlm.nih.gov
- Journal of Clinical Oncology (Society for Integrative Oncology and ASCO). “Mao JJ, Ismaila N, Bao T, et al. "Integrative Medicine for Pain Management in Oncology: Society for Integrative Oncology-ASCO Guideline." J Clin Oncol, 2022. PubMed. DOI: 10.1200/JCO.22.01357.” pubmed.ncbi.nlm.nih.gov
- U.S. Food and Drug Administration, Center for Devices and Radiological Health. “510(k) premarket notification K033268, acupressure wristband, clearance letter date-stamped January 7, 2004 (product code MVV; indications for use; class recorded as Unclassified in the letter and Class II in the summary).” accessdata.fda.gov
- Advertising Standards Authority (United Kingdom). “ASA Ruling on Sea-Band Ltd, complaint reference A12-197943, 5 June 2013 (complaints upheld under CAP Code rules 3.1, 3.7, 3.11 and 12.1).” asa.org.uk
- National Center for Complementary and Integrative Health, National Institutes of Health. “Travel-Related Ailments and Complementary Health Approaches (Clinical Digest, June 2024): research does not support acupressure or magnets for motion sickness.” nccih.nih.gov
- National Center for Complementary and Integrative Health, National Institutes of Health. “Complementary Health Approaches for Chronic Pain: What the Science Says (Clinical Digest, September 2022): cancer pain findings for acupuncture and acupressure.” nccih.nih.gov
- Journal of Bodywork and Movement Therapies. “Leung B, Treleaven J, Dinsdale A, Marsh L, Thomas L. "Serious adverse events associated with conservative physical procedures directed towards the cervical spine: A systematic review." J Bodyw Mov Ther, 2025. PubMed. DOI: 10.1016/j.jbmt.2024.10.018.” pubmed.ncbi.nlm.nih.gov